Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

945

Analysis of Systemic Sclerosis-associated Genes in a Turkish Population

F David Carmona1, Ahmet Mesut Onat2, Tamara Fernández-Aranguren2

  • 1From the Instituto de Parasitología y Biomedicina "López-Neyra," IPBLN-CSIC, PTS Granada, Granada, Spain; Department of Rheumatology, University of Gaziantep, Gaziantep; Division of Rheumatology, Marmara University, School of Medicine; Department of Rheumatology, Istanbul Bilim University, Istanbul, Turkey; Division of Rheumatology, Department of Internal Medicine, University of Michigan; Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.F.D. Carmona, PhD, Instituto de Parasitología y Biomedicina "López-Neyra," IPBLN-CSIC, PTS Granada; A.M. Onat, MD, Department of Rheumatology, University of Gaziantep; T. Fernández-Aranguren, BSc, Instituto de Parasitología y Biomedicina "López-Neyra," IPBLN-CSIC, PTS Granada; A. Serrano-Fernández, BSc, Instituto de Parasitología y Biomedicina "López-Neyra," IPBLN-CSIC, PTS Granada; G. Robledo, BSc, Instituto de Parasitología y Biomedicina "López-Neyra," IPBLN-CSIC, PTS Granada; H. Direskeneli, MD, Division of Rheumatology, Marmara University, School of Medicine; A.H. Sawalha, MD, Division of Rheumatology, Department of Internal Medicine, University of Michigan, and the Center for Computational Medicine and Bioinformatics, University of Michigan; S. Yavuz, MD, Department of Rheumatology, Istanbul Bilim University; J. Martín, MD, PhD, Instituto de Parasitología y Biomedicina "López-Neyra," IPBLN-CSIC, PTS Granada. dcarmona@ipb.csic.es.

The Journal of Rheumatology
|May 3, 2016
PubMed
Abstract

Keywords:
GENETICSSYSTEMIC SCLEROSISTURKEY

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75